Successful Scale Up of a High Yielding Viral Vetor Suspension Platform to 500 L


July 12, 2022

As gene therapies move toward commercialization, the journey to manufacture a high-quality product while achieving economies of scale and reducing facility footprint, can be challenging. Developing and optimizing your process development early on is critical for your company’s long-term success. In this webinar, we will present our scalable integrated platforms for viral vector production in both adherent and suspension cell cultures.

More information

View full calendar